71
Participants
Start Date
August 31, 2007
Study Completion Date
February 29, 2008
Placebo
Subjects will be given either Placebo or PF-04603629.
PF-04603629
Subjects will be given either Placebo or PF-04603629. The specific dose of PF-04603629 given depended on the Cohort to which the patient was assigned. Doses administered ranged from 1 mg to 70 mg.
Pfizer Investigational Site, San Antonio
Pfizer Investigational Site, Phoenix
Lead Sponsor
Pfizer
INDUSTRY